Journal Club - Recent Additions

May - 2019


Showing Journal 1 of 9

Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients With Sepsis-Associated Coagulopathy- The SCARLET Randomized Clinical Trial

JL Vincent, B Francois, I Zabolotskikh et al for The Scarlet Study Group JAMA, 2019, online first May 2019


Does administration of a recombinant human soluble thrombomodulin reduce mortality of critically ill patients with sepsis-associated coagulopathy?

The rationale behind asking this question;

  • Sepsis-associated coagulopathy, defined as prolonged INR and reduced...


Previous Comments

Well conducted clinical trial,even if its negative trial to reduce mortality !!!
FREOKUMAR-04 Dec, 2019 02:54:50 PM